Wang

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 BIAO WANG, et al., Case No. 21-cv-06028-PCP

8 Plaintiffs,

ORDER GRANTING LEAVE TO

9 v. AMEND

10 ZYMERGEN INC., et al., Re: Dkt. No. 234 Defendants. 11

12 13 Lead plaintiff Biao Wang has moved for leave to file a second amended complaint. Dkt. 14 No. 234. For the reasons that follow that motion is granted. 15 I. Background 16 The current operative complaint in this case, Dkt. No. 78, was filed February 24, 2022. It 17 includes a claim under Section 11 of the Securities Act against Zymergen, a group of individual 18 defendants, and a group of underwriter defendants; as well as a claim under Section 15 of the 19 Securities Act against the individual defendants and a third set of defendants, the controlling 20 stockholders, which included a group of SoftBank parties,1 a group of DCVC parties,2 and a group 21 of True Ventures parties.3 On November 29, 2022 the Court dismissed the Section 15 claim on the 22 basis that there were not “sufficient allegations to…